Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TGC-14 reported for 2024 by RAS

2/20/25 TGKN

Mechel reported for 2024 by IFRS

2/20/25 MTLR

Mechel summarized the results of production and sales in 2024

2/20/25 MTLR

SPB Exchange will add 16 securities to the trades

2/20/25 SPBE

T-Technologies will determine the amount of dividends in March

2/20/25 T

Yandex plans to pay dividends at the end of 2024

2/20/25 YDEX

UTair passenger traffic on airplanes in January increased by 5.5%

2/20/25 UTAR

Promomed's revenue in 2024 increased by 33%

2/20/25 PRMD

Yandex reported for 2024 by IFRS

2/20/25 YDEX

Positive Technologies has entered the antivirus market

2/20/25 POSI